Last updated: July 28, 2025
Introduction
Patent KR20070011466 pertains to a pharmaceutical invention filed under South Korea’s patent regime, aiming to address specific medical needs through novel compounds, formulations, or therapeutic methods. This analysis explores the patent’s scope and claims, situates it within the broader patent landscape, and assesses potential strategic implications for stakeholders including pharmaceutical companies, generics manufacturers, and R&D entities.
1. Patent Overview and Filing Context
KR20070011466 was filed with the Korean Intellectual Property Office (KIPO) in 2007, and its publication number indicates a priority date potentially linked to earlier filings internationally or domestically. The patent appears to focus on a particular drug compound or a therapeutic formulation, consistent with patent strategies seeking exclusivity over innovative medicinal entities.
The patent likely falls under pharmaceutical-specific classifications, such as the IPC classes A61K (preparations for medical, dental, or hygienic purposes) and C07D (heterocyclic compounds), which are typical for drug inventions.
2. Scope and Claims of KR20070011466
a. Core Claim Structure
The patent's claims define the legal boundaries of the invention, generally beginning with independent claims followed by dependent claims that specify particular embodiments or enhancements.
-
Independent Claims:
The core claims generally describe a novel chemical entity or a specific formulation with therapeutic efficacy. They may encompass novel compounds, salts, esters, or prodrugs with specified structural features that differentiate them from prior art.
-
Dependent Claims:
These elaborate on the independent claim, detailing specific substituents, dosage forms, methods of synthesis, or therapeutic use indications to fortify the invention's scope.
b. Patent Scope Analysis
Without access to the specific claim text, typical features for a patent of this class include:
-
Chemical Composition Scope:
Claims covering a novel heterocyclic or therapeutic compound with specified structural formulas. Such claims often include a broad genus definition with narrower species encompassed as dependent claims.
-
Method of Use:
Claims may cover methods for treating particular conditions, such as cancers, neurological disorders, or infectious diseases, using the claimed compounds.
-
Formulation Claims:
Salts, solvates, or combinations with carriers enhancing bioavailability or stability.
-
Synthesis Processes:
Claims covering specific synthetic routes that improve yields, purity, or reaction conditions.
c. Patent Claim Novelty and Inventive Step
The claims aim to carve out a novel chemical space not previously disclosed. Patentability hinges on demonstrating that the invention exhibits inventive step over prior art, including earlier patents, scientific publications, or known therapeutic methods.
3. Patent Landscape and Strategic Positioning
a. Existing Patent Family and Related Patents
The scope of parallel filings internationally (e.g., WO, US, EP) would influence the patent’s strength. Similar patents or publication references could reveal prior art that the KR20070011466 claims must navigate around or carve out specific niches.
b. Competitive Landscape
South Korea has a robust pharmaceutical industry characterized by large entities like Samsung Biologics and numerous smaller biotech companies. The patent landscape around similar compounds would include prior patents, granted or pending, that protect specific classes of drugs or therapeutic mechanisms.
c. Legal Environment
South Korea’s patent enforcement rigor and the potential for patent challenges or oppositions necessitate a strong, well-defined claim scope. The patent’s validity could be tested on grounds of novelty, inventive step, and inventive description, especially if similar compounds exist.
d. Patent Term and Lifecycle
Filed in 2007, the patent would have expiration around 2027, assuming standard 20-year terms from the filing date. This timeline influences how companies strategize around patent expiry, generics entry, and further innovation pipelines.
4. Strategic Implications
-
Protection of Novelty:
The claim breadth is critical to defend against competitors who may attempt to design-around or develop similar compounds.
-
Licensing and Collaborations:
The patent can serve as a bargaining chip in licensing negotiations or strategic alliances, particularly if the compound demonstrates significant therapeutic value.
-
Filing Continuations and Divisional Applications:
To extend protection or refine claim scope, patent holders may pursue continuations-in-part (CIPs) or divisional filings based on the initial patent.
-
Potential Challenges:
Given the field’s dynamic nature, competitors may challenge the patent’s validity or seek to bypass it using alternative compounds or formulations.
5. Conclusion
Patent KR20070011466’s claims likely cover a specific chemical entity or therapeutic method with notable scope within South Korea. Its position in the patent landscape depends on the breadth of its claims, prior art references, and strategic filings in other jurisdictions. Stakeholders must carefully examine the claim language for strength and potential vulnerabilities to effectively navigate patent rights around this invention.
Key Takeaways
- The patent’s scope revolves around a novel drug compound or formulation, with claims carefully structured to balance breadth and specificity.
- It forms a critical part of South Korea’s pharmaceutical patent landscape, influencing exclusivity and market strategy for related therapies.
- Vigilant monitoring of potential prior art or competing patents is necessary to defend or challenge its validity.
- Strategic patent management, including licensing or territorial extensions, can maximize the patent’s commercial value.
- Understanding the patent’s expiration timeline is essential for planning lifecycle management, especially in fast-evolving therapeutic areas.
Frequently Asked Questions (FAQs)
Q1. What types of claims are typical in South Korea drug patents like KR20070011466?
Most often, they include chemical composition claims, method-of-use claims, formulation claims, and sometimes process claims for synthesizing the compound, each intended to secure comprehensive protection.
Q2. How does KR20070011466 compare with international patents for similar drugs?
While detailed comparison requires specific claim text, Korean patents generally align with international patent standards, covering core compounds and uses. Cross-jurisdictional filings can bolster protection and market coverage.
Q3. What are common vulnerabilities of patents like KR20070011466?
They include narrow claim scope, gaps in prior art disclosures, or challenges based on obviousness. Precise claim drafting and thorough patent prosecution can mitigate these vulnerabilities.
Q4. How does the patent landscape affect potential generic entry in South Korea?
The patent’s validity, scope, and expiry date directly impact market exclusivity. Upon patent expiration or invalidation, generic manufacturers can seek approval, increasing competition.
Q5. What strategic steps should patent holders consider for maximizing patent value?
They should consider defending against validity challenges, pursuing international patent family coverage, exploring licensing opportunities, and planning for lifecycle management aligned with therapeutic developments.
References
- Korean Intellectual Property Office. Publication KR20070011466.
- WIPO. World Patent Data filings for similar compounds or therapeutic classes.
- South Korea Patent Law: Standards for novelty, inventive step, and patentability.
